Heterologous ALG was administered to ten canine recipients of renal homografts and one recipient of an orthotopic liver. Treatment was started after rejection was well established. Death from homograft failure was thereby significantly delayed and in several experiments the rejection was at least partially reversed.
|Original language||English (US)|
|Number of pages||4|
|State||Published - Sep 1969|
ASJC Scopus subject areas